Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06562023
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Botulinum Toxin Versus Mesotherapy on Enhancement of Facial Scarring A Randomized Controlled Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Most of the bodys tissues can undergo wound repair following a disruption of tissue integrity Upon healing these wounds result in scar formation The scars widen when the overlying musculature pulls apart suture lines Botulinum Toxin A BTA is known to prevent fibroblast proliferation and it also induces temporary muscle paralysis Also mesotherapy is the non-invasive transdermal injection which can aid the skin to increase collagen and elastin production Thus both techniques are eligible for enhancement of facial scars
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None